Christopher Anzalone

Arrowhead Pharmaceuticals, Inc. (ARWR)
     Pasadena, CA
Total Compensation for Fiscal Year Ending in 2024: $12,423,473
Salary $951,012
Bonus $0
Value of Stock Awards $10,319,000
Value of Option Awards $0
Non-Equity Incentive Plan Compensation $1,152,000
Change in Pension Value and Deferred Compensation Earnings $0
All Other Compensation $1,461
Total $12,423,473
Arrowhead Pharmaceuticals, Inc. disclosed its CEO pay was
70
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?